Catalyst Wire Dossier Catalyst Wire Dossier

CCL2-LPM

· Osprey Pharmaceuticals USA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CCL2-LPM, covering 2010-06-02 to 2010-06-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy [Phase 1]

See pricing